Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
 wosene.asefa@nih.gov
240-276-6422 		5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
 kajal.biswas2@nih.gov
240-276-5614 		5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
 brian.cholewa@nih.gov
240-276-7545 		5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
 john.clifford@nih.gov
202-235-4482 		5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
 vignesh.gunasekharan@nih.gov
240-276-5814 		5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
 altaf.mohammed@nih.gov
240-276-6082 		5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
 ancy.nalli@nih.gov
202-276-5265 		5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
 shizuko.sei@nih.gov
240-276-5005 		5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
 robert.shoemaker@nih.gov
240-276-7077 		5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
 anda.vlad@nih.gov
240-276-6422 		5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name PI Organization Title Grant Number Program Official
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

 Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 5R01CA281293-03 Maria Silvina Frech, Ph.D., M.S.
Moses, John Edward

Cold Spring Harbor Laboratory
United States

 Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer 1UG3CA290364-01A1 Altaf Mohammed, Ph.D.
Mosher, Catherine E

Indiana University Indianapolis
United States

 Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mu, Ping

Yale University
United States

 Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Mugo, Nelly Rwamba

Kenya Medical Research Institute (Kemri)
United States

 KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH 3UG1CA285132-03S1 Maria Silvina Frech, Ph.D., M.S.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

 The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

 Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa 3R37CA306827-01S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

 Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs 3R34CA284983-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Murenzi, Gad

Research For Development
United States

 Rwanda CASCADE Clinical Trials Site for cervical cancer prevention 5UG1CA284908-03 Maria Silvina Frech, Ph.D., M.S.
Mustian, Karen M.

University Of Rochester
United States

 URCC NCORP Research Base 3UG1CA189961-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Muzumdar, Mandar Deepak

Yale University
United States

 Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics 1R01CA296916-01
Mwesigwa, Betty

Makerere University Walter Reed Project
United States

 Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) 5UG1CA275412-04 Maria Silvina Frech, Ph.D., M.S.
Nabavi, Sheida

University Of Connecticut Storrs
United States

 SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

 CAPRISA CASCADE Clinical Trials Network Clinical Research Site 5UG1CA284671-03 Maria Silvina Frech, Ph.D., M.S.
Nappi, Lucia

Provincial Health Services Authority
United States

 Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 Guillermo Marquez, Ph.D.